The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function: Potential significance for attention-deficit hyperactivity disorder

Archives of General Psychiatry

Volumn 53, Issue 5, 1996, Pages 448-455

  Arnsten, Amy F T ^a   Steere, Jenna C ^a   Hunt, Robert D ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ctr Attention Hyperactivity Disord   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; NORADRENALIN; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ATTENTION DEFICIT DISORDER; COGNITION; HYPERACTIVITY; MONKEY; NEUROPATHOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRESYNAPTIC MEMBRANE; SHORT SURVEY;

EID: 0029924275     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830050084013     Document Type: Short Survey

References (130)

1. Roeltgen DP, Schneider JS. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys. Behav Brain Res. 1994;60:115-124
2. Lou HC, Henriksen L, Bruhn P, Borner H, Bieber Nielson J. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol. 1989; 46:48-52.
3. Hynd GW, Hern KL, Novey ES, Eliopulos D, Marshall R, Gonzalez JJ, Voeller KK. Attention deficithyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339-347.
4. Shaywitz BA, Klopper JH, Gordon JW Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Arch Neurol 1978:35:463-469.
5. Shaywitz BA, Cohen DJ, Bowers MB. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. J Pediatr 1977;90.67-71.
6. Shaywitz BA, Teicher MH, Cohen DJ, Anderson GM, Young JG, Levitt P Dopaminergic but not noradrenergic modulation of hyperactivity and performance deficits in the developing rat pup. Psychopharmacology. 1984;82:73-77.
7. Raskin LA, Shaywitz BA, Anderson GM, Cohen DJ, Teicher MH, Liakis J. Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat. Pharmacol Biochem Behav. 1983; 19:743-749.
8. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995; 56:993-998.
9. Shekim WO, Dekirmenjian H, Chapel JL. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine. Am J Psychiatry. 1979;136.667-671.
10. Carli M, Robbins TW, Evenden JL, Everitt BJ Effect of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction task in rats implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res. 1983,9:361-380.
11. Roberts DCS, Price MTC, Fibiger HC The dorsal tegmental noradrenergic projection: an analysis of its role in maze learning. J Comp Physiol Psychol. 1976;90:363-372.
12. Pearlson GD, Robinson RG. Suction lesions of the frontal cerebral cortex in the rat induce asymmetrical behavioral and catecholaminergic responses. Brain Res. 1981;218.233-242.
13. Mattes JA The role of frontal lobe dysfunction m childhood hyperkinesis. Compr Psychiatry. 1980;21:358-369.
14. Chelune GJ, Ferguson W, Koon R, Dickey TO. Frontal lobe disinhibition in attention deficit disorder Child Psychiatry Hum Dev 1986;16:221-234.
15. Gorenstein EE, Mammato CA. Performance of inattentive-overactive children on selected measures of prefrontal-type function J Clin Psychol. 1989;45:619-632.
16. Loge DV, Staton RD, Beatty WW. Performance of children with ADHD on tests sensitive to frontal lobe dysfunction J Am Acad Child Adolesc Psychiatry 1989,29:540-545.
17. Benson DF The role of frontal dysfunction in attention deficit hyperactivity disorder. J Child Neurol 1991,6 S9-S12
18. Barkley RA, Grodzinsky G, DuPaul GJ. Frontal lobe functions in attention deficit disorder with and without hyperactivity. a review and research report. J Abnorm Child Psychol. 1992; 20:163-188
19. Shue KL, Douglas VI Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn 1992;20:104-124.
20. Drewe EA, Go/no-go learning after frontal lobe lesions in humans. Cortex. 1975;11:8-16
21. Knight RT, Hillyard SA, Woods DL, Neville HJ. The effects of frontal cortex lesions on eventrelated potentials during auditory selective attention Electroencephalogr Clin Neurophysiol. 1981,52 571-582.
22. Wiikins AJ, Shallice T, McCarthy R Frontal lesions and sustained attention. Neuropsychologia. 1987;25-359-365
23. Yamaguchi S, Knight RT. Gating of sornatosensory input by human prefrontal cortex. Brain Res. 1990;521.281-288.
24. Brazelli M, Columbo N, Della Sala S, Spinnler H. Spared and impaired cognitive abilities after bilateral frontal damage Cortex. 1994;30 27-51.
25. Della Sala S, Marchetti C, Spinnler H. The anarchic hand. a frontal-mesial hyperkinetic sign. In: Boller F, Grafman J, eds. Handbook of Neuropsychology. Amsterdam, Holland: Elsevisr Science; 1994:233-255.
26. Butter CM, Snyder DR, McDonald JA. Effects of orbital frontal lesions on aversive and aggressive behaviors in rhesus monkeys. J Comp Physiol Psychol. 1970;72:132-144.
27. Bartus RT, Levere TE. Frontal decortication in rhesus monkeys. a test of the interference hypothesis Brain Res. 1977;119:233-248
28. Malmo RB. Interference factors in delayed response in monkeys after removal of frontal lobes. J Neurophysiol 1942,5 295-308.
29. Mesulam M-M. A cortical network for directed attention and unilateral neglect Ann Neurol. 1981; 10309-325.
30. Woods DL, Knight RT. Electrophysiological evidence of increased distractibility after dorsolateral prefrontal lesions. Neurology. 1986,36: 212-216.
31. Chao LL, Knight RT. Human prefrontal lesions increase distractibility to irrelevant sensory inputs. Neuroreport. 1995;6.1605-1610.
32. Blumer D, Benson DF. Personality changes with frontal and temporal lobe lesions. In: Benson DF, Blumer D, eds. Psychiatric Aspects of Neurologic Disease. New York, NY: Grune & Stration; 1975
33. Stuss DT, Gow CA, Hetherington CR. 'No longer Gage': frontal lobe dysfunction and emotional changes. J Consult Clin Psychol. 1992;60:349-359.
34. Starkstein SE, Fedoroff P, Berthier ML, Robinson RG. Manic-depressive and pure manic states after brain lesions. Biol Psychiatry. 1991,29-149-158.
35. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D. Brain morphology in developmental dyslexia and attention deficit disorder/ hyperactivity. Arch Neurol. 1990;47:919-926.
36. Swanson JM, Posner M, Potkin S, Bonforte S, Youpa D, Fiore C, Cantwell D, Crinelia F Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J Child Neurol 1991,6.S119-S127.
37. Satterfield JH, Schell AM, Nicholas T, Backs RW. Topographic study of auditory event-related potentials in normal boys and boys with attention deficit disorder with hyperactivity. Psychophysiology. 1988;25:591-606.
38. Lou HC, Henriksen L, Bruhn P. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol. 1984; 41 825-829.
39. Lou HC, Hennksen L, Bruhn P. Focal cerebral dysfunction in developmental learning disabilities. Lancet. 1990;335:8-11.
40. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AG, Minkunas DV, Herscovitch P, Yamada EM, Cohen RM Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1993;50:333-340.
41. Matochik JA, Liebenauer LL, King CA, Szymanski HV, Cohen RM, Zametkin AJ. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment Am J Psychiatry. 1994;151 658-664.
42. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H. Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI. J Learning Disabil. 1991;24-141-146.
43. Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC, Hamburger SD, Rapoport JL. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry. 1994,151.665-669.
44. Goldman-Rakic PS. Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory In Plum F, ed. Handbook of Physiology, The Nervous System, Higher Functions of the Brain. Bethesda, Md: American Physiological Society; 1987;5:373-417.
45. Goldman PS, Rosvold HE. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp Neurol. 1970;27:291-304
46. Funahashi S, Bruce CJ, Goldman-Rakic PS. Visuospatial coding in primate prefrontal neurons revealed by oculomotor paradigms. J Neurophysiol. 1990;63:814-831.
47. Wilson FAW, O Scalaidhe SP, Goldman-Rakic PS. Dissociation of object and spatial processing domains in primate prefrontal cortex Science 1993,260:1955-1958
48. Selemon LD, Goldman-Rakic PS. Common cortical and subcortical target areas of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed network subserving spatially guided behavior. J Neurosci. 1988;8.4049-4068.
49. Cavada C, Goldman-Rakic PS. Posterior parietal cortex in rhesus monkey, I: parcelation of areas based on distinctive limbic and sensory corticocortical connections J Comp Neurol 1989; 287:393-421.
50. Cavada C, Goldman-Rakic PS Posterior parietal cortex in rhesus monkey, II evidence for segregated corticocortical networks linking sensory and limbic areas with the frontal lobe J Comp Neurol 1989;287:422-445.
51. Funahashi S, Bruce CJ, Goldman-Rakic PS, Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. J Neurophysiol 1989;61:331-349.
52. Goldman-Rakic PS, Selemon LD, Schwartz ML Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience. 1984;12:719-743.
53. Martin-Elkins CL, Horel JA Cortical afferents to behaviorally defined regions of the inferior temporal and parahippocampal gyri as demonstrated by WGA-HRP J Comp Neurol. 1992, 321:177-192.
54. Bates JF, Wilson FAW, Ò Scalaidhe SPO, Goldman-Rakic PS Area TE connections with inferior prefrontal regions responsive to complex objects and faces. Soc Neurosci Abstracts 1994; 20-1054.
55. Schwartz ML, Goldman-Rakic PS, Single cortical neurones have axon collaterals to ipsilateral and contralaterat cortex in fetal and adult primates. Nature. 1982;299:154-156
56. Pardo JV, Pardo PJ, Janer KW, Raichle ME. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm Proc Natl Acad Sci U S A 1990;87:256-259.
57. Goldman PS, Nauta WJH. An intricately patterned prefronto-caudate projection in the rhesus monkey. J Comp Neurol 1977,171:369-386
58. Selemon LD, Goldman-Rakic PS Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 1985,5:776-794.
59. McGuire PK, Bates JF, Goldman-Rakic PS. Interhemispheric integration, I: symmetry and convergence of the corticocortical connections of the left and right principal sulcus and the left and right supplementary motor area in the rhesus monkey. Cereb Cortex. 1991;1:390-407.
60. Bates JF, Goldman-Rakic PS. Prefrontal connections of medial motor areas in the rhesus monkey. J Camp Neurol. 1993,335:1-18
61. Goldman-Rakic PS. Motor control function of the prefrorttal cortex. In: Porter R, ed. Motor Areas of the Cerebral Cortex. Ciba Foundation Symposium No. 132 Chichester, England: Wiley & Sons; 1987:187-200.
62. Goldman-Rakic PS, Bates JF. Chafee MV The prefrontal cortex and internally generated motor acts. Curr Opin Neurobiol. 1992;2 830-835.
63. Jones EG, Powell TPS. An anatomical study of converging sensory pathways within the cerebral cortex of the monkey. Brain. 1970;93:793-820
64. Petrides M, Pandya DN. Association fiber pathways to the frontal cortex fram the superior temporal region in the rhesus monkey. J Comp Neu-ml. 1988,273:52-66
65. Aggleton JP, Burton MJ, Passingham RE. Cortical and subcortical afferents to the amygdala of the rhesus monkey (macaca mulatta). Brain Res. 1980;190:347-368.
66. Amaral DG, Price JL, Pitkznen A, Carmichael ST. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP, ed. The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction New York, NY Wiley-Liss Inc; 1992:1-66.
67. Porrino LJ, Goldman-Rakic PS Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol. 1982; 205 63-76.
68. Levitt P, Rakic P, Goldman-Rakic P. Regionspecific distribution of catecholamme affernets in primate cerebral cortex. a fluorescence histochemical analysis J Comp Neurol. 1984; 227:23-36
69. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific J Neurosci. 1987;7:279-290.
70. Lewis DA, Morrison JH. The noradrenergic innervation of monkey prefrontal cortex: a dopamine beta hydroxylase immunohistochemical study. J Comp Neurol. 1989;282:317-330.
71. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;215:929-932
72. Sawaguchi T, Matsumura M, Kubota K Catecholammergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol. 1990;63: 1385-1400.
73. Arnsten AFT, Cai JX, Murphy BL, Goldman-Rakic PS Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys Psychopharmacology 1994; 116:143-151.
74. Arnsten AF, Cai JX, Steere JC, GoldmanRakic PS Dopamine D-2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J Neurosci 1995;15:3429-3439.
75. Berridge CW, Arnsten AFT, Foote SL Noradrenergic modulation of cognitive function, clinical implications of anatomical, electrophysiological and behavioural studies in animal models Psychol Med. 1993;23:557-564.
76. Coull JT. Pharmacological manipulations of the α-2 noradrenergic system: effects on cognition. Drugs Aging. 1994;5:116-126.
77. Arnsten AFT, Goldman-Rakic PGR. Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey Brain Res. 1984;306:9-18
78. Sara SJ, Herve-Minvielle A. Inhibitory influence of frontal cortex on locus coeruleus. Proc Natl Acad Sci U S A 1995,92:6032-6036.
79. Kubiak P, Ivanova S, Rajkowski J, Aston-Jones G Contrasting responses of monkey locus coeruleus neurons to conditioned vs unconditioned stimuli: relationship to arousal, performance and vigilance. Soc Neurosci Abstracts 1995,21:2092.
80. Arnsten AF, Goldman-Rakic PS. α-2 Adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science. 1985;230:1273-1276.
81. Cai JX, Ma Y, Xu L, Hu X. Reserpine impairs spatial working memory performance in monkeys: reversal by the α-2-adrenergic agonist clonidine. Brain Res. 1993;614:191-196
82. Arnsten AFT, Cai JX, Goldman-Rakic PS The α-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects. evidence for α-2 receptor subtypes J Neurosci. 1988;8.4287-4298
83. Arnsten AFT, Leslie FM. Behavioral and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 [2-imidazoline-2-yl amino] quinoxaline): evidence for cognitive enhancement at an α-2 adrenoceptor subtype. Neuropharmacology. 1991,30:1279-1289.
84. Arnsten AFT, Contant TA. α-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacol 1992;108:159-169.
85. Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW. Cloning, sequencing, and expression of the gene encoding for the human platelet α-2-adrenergic receptor. Science 1987;238.650-656.
86. Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK Cloning and expression of a human kidney cDNA for an α-2 adrenergic receptor subtype. Proc Natl Acad Sci U S A. 1988;85:6301-6305
87. Lomasney JW, Lorenz W, Allen LF, King K, Regan JW, Yang-Feng TL, Caron M, Lefkowitz RJ. Expansion of the α-2 adrenergic family: cloning and characterization of a human α-2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci U S A 1990;87:5094-5098.
88. Scheinin M, Lomasney JW, Hayden-Hixson DM, Sehambra UB, Caron MG, Lefkowitz RJ, Fremeau RT. Distribution of α-2-adrenergic receptor subtype gene expression in rat brain Mol Brain Res. 1994;21:133-149
89. Nicholas AP, Pieribone V, Hökfelt T. Distributions of mRNAs for α-2-adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 1993,328:575-594
90. Buzsaki G, Kennedy B, Solt VB, Ziegler M. Noradrenergic control of thalamic oscillation. the role of alpha-2 receptors Eur J Pharmacol 1991; 3:222-229
91. Reis DJ, Granata AR, Joh TH, Ross CA, Ruggiero DA, Park DH. Brain stem catecholamine mechanisms in tonic and reflex control of blood pressure. Hypertension 1984;6(SII):7-15.
92. Aoki C, Go C-G, Venkatesan C, Kurose H Perikaryal and synaptic localization of α-2A-adrenergic receptor-like immunoreactivity. Brain Res. 1994,650:181-204.
93. Uhten S, Wikberg JES. Delineation of rat kidney α-2A and α-2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modeling reveals that guanfacine is an α-2A-selective compound. Eur J Pharmacol. 1991; 202:235-243.
94. Marjamaki A, Luomala K, Ala-Uotila S, Scheinin M. Use of recombinant human α-2-adrenoceptors to characterize subtype selectivity of antagonist binding. Eur J Pharmacol. 1993;246:219-226.
95. Steere JC, Arnsten A The alpha-2 noradrenergic agonist, guanfacine, improves delayed response performance and calms behavior in young monkeys: relevance to attention deficit disorder. Soc Heurosci Abstracts. 1994,20: 831.
96. Svensson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975;92:291-306.
97. U'Prichard DC, Bechtel WD, Rouot BM, Snyder SH. Multiple apparent α-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol Pharmacol. 1979,16:47-60.
98. Van Zwieten PA, Timmermans PBMWM, Van Brummelen P Role of alpha-adrenoceptors in hypertension and in antihypertensive drug treatment. Am J Med. 1984:17-25.
99. Berridge CW, Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 1991,11.3135-3145.
100. Schneider JS, Kovelowski CJ Chronic exposure to low doses of MPTP, I: cognitive deficits in motor asymptomatic monkeys. Brain Res. 1990;519-122-128.
101. Arnsten AFT, Cai JX. Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging. 1993; 14:597-603.
102. Li B-M, Mei Z-T. Delayed response deficit induced by local injection of the α-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys Behav Neural Biol. 1994;62:134-139.
103. Li B-M, Hu X-T, Mei ZT. Prefrontal injection of the alpha-2-adrenergic antagonist yohimbine impairs performance of a delayed go/no-go task in monkeys. Acta Physiol Sinica. 1994;46:249-257.
104. Li B-M, Mei Z-T. Alpha-2 adrenergic modulation of prefrontal neuronal activity related to working memory in monkeys. Presented at the 3rd Congress of the Federal Asian and Oceanian Physiological Societies, 1995. Abstract S9-3(0).
105. Arnsten AFT, Goldman-Rakic PS Analysis of α-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys. Neurobiol Aging. 1990,11:58 3-590.
106. Sirviö J, Riekkmen P, Vajanto I, Koivisto E, Riekkinen PJ. The effects of guanfacine, α-2 agonist, on the performance of young and aged rats in spatial navigation task Behav Neural Biol. 1991;56101-107.
107. Carlson S, Tanila H, Rama P, Mecke E, Pertovaara A. Effects of medetomidine, an α-2 adrenoceptor agonist, and atipannezole, and α-2 antagonist, on spatial memory performance in adult and aged rats. Behav Neural Biol. 1992; 58:113-119.
108. Jackson WJ, Buccafusco JJ. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol Biochem Behav. 1991;39:79-84.
109. Rama P, Hietanen JK Alpha-2 adrenergic function and visual selective attention in monkeys Soc Neurosci Abstracts 1995,21:2092.
110. Morel A, Bullier J Cortical connections of intraparietal and inferotemporal visual areas in the macaque monkey, a double-labeling study Abstracts Soc Neurosci. 1989;15 111.
111. Alexander GE, Newman JD, Symmes D. Convergence of prefrontal and acoustic inputs upon neurons in the superior temporal gyrus of the awake squirrel monkey. Brain Res 1976;116 334-338.
112. Knight RT, Scabini D, Woods DL. Prefrontal cortex gating of auditory transmission in humans. Brain Res. 1989,504:338-342
113. Müller-Preuss P, Newman JD, Jürgens U. Anatomical and physiological evidence for a relationship between the 'cingular' vocalization area and the auditory cortex in the squirrel monkey. Brain Res 1980;202:307-315
114. Bench CJ, Frith CD, Grasby PM, Fristen KJ, Paulesu E, Frackowiak RSJ, Dolan RJ Investigations of the functional anatomy of attention using the Stroop test Neuropsychologia 1993;31:907-922.
115. Casey BJ, Cohen JD, Noll DC, Forman S, Rapoport JL Activation of the anterior cingulate during the Stroop conflict paradigm using functional MRI Soc Neurosci Abstracts. 1993; 19:1285.
116. Roland PE. Metabolic measurements of the working frontal cortex in man. Trends Neurosci 1984; 7:430-435.
117. Mangun GR, Heinze HJ, Burchert W, Hinrichs H, Scholz M, Munte TF, Gos A, Hundeshagen H, Gozzaniga MS, Hillyard SA. Combined PET and ERP studies of visual spatial selective attention in humans Soc Neurosci Abstracts. 1993; 19.1285
118. Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex Neurosci Lett. 1993;163 109-113.
119. Steere JC, Arnsten AFT. The alpha-2 noradrenergic agonist, guanfacine, improves visual object discrimination reversal in rhesus monkeys Soc Neurosci Abstracts. 1995;21:195.
120. Rajkowski J, Ivanova S, Kubiak P, Aston-Jones G. Improved vigilance performance in monkey associated with altered locus coeruleus activity after clonidine. Soc Neurosci Abstracts 1995;21:2092.
121. Fields RB, Van Kammen DP, Peters JL, Rosen J, Van Kammen WB, Nugent A, Stipetic S, Linnoila M. Clonidine improves memory function in schizophrenia independently from change in psychosis. Schizophr Res. 1988;1:417-423.
122. Mair RG, McEntee WJ. Cognitive enhancement in Korsakoffs psychosis by clonidine: a comparison with 1-dopa and ephedrine Psychopharmacology. 1986;88-374-380.
123. Moffoot A, O'Carroll RE, Murray C, Dougall N, Ebmeier K, Goodwin GM. Clonidine infusion increases uptake of Tc-exametazamine in anterior cingulate cortex in Korsakoff's psychosis. Psychol Med 1994;24:53-61.
124. McEntee WJ, Mair RG The Korsakoff syndrome, a neurochemical perspective. Trends Neurosci 1990;13340-344.
125. Coull JT, Middleton HC, Robbins TW, Sahakian BJ Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology 1995,120:311-321
126. Hunt RD, Minderaa RS, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial J Am Acad Child Psychiatry 1985;24:617-629.
127. Hunt RD, Capper L, O'Connell P. Clonidine in child and adolescent psychiatry. J Child Adolesc Psychiatry 1990,1:87-102
128. Hunt RD, Arnsten AFT, Asbell MD. An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 1995;34.50-54
129. Chappell PB, Riddle MA, Scahill L, Lynch K, Schultz R, Arnsten AFT, Leckman JF, Cohen DL Guanfacine treatment of comorbid attention deficit hyperactivity disorder and Tourette's syndrome. preliminary clinical experience. J Am Acad Child Adolesc Psychiatry. 1995;34:1140-1146.
130. Horrigan JP, Barnhill LJ Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. J Child Adolesc Psychopharm. 1995, 5:215-223.